Clinical Trial: Glaucoma Screening Using An Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program

U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07243665) titled 'Glaucoma Screening Using An Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program' on Nov. 16.

Brief Summary: Glaucoma is major cause of irreversible blindness and is characterized by optic nerve damage and visual field loss. Screening for glaucoma is challenging due to lack of a simple, accurate, cost-efficient and standardized process. Artificial intelligence, (AI) especially deep learning (DL) algorithms have potential to automate glaucoma detection, but have to be evaluated in real world settings, before public deployment. This study aims to evaluate the screening accuracy of a DL algorith...